{"filing":{"accession_number":"0001127703-26-000024","cik":"0001127703","ticker":"PRA","company_name":"PROASSURANCE CORP","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"pra-20260623.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1127703/000112770326000024/pra-20260623.htm"},"events":[{"id":13299,"run_id":11803,"accession_number":"0001127703-26-000024","anchor_item_number":"8.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"The filing discloses the completion of all regulatory approvals for a material merger transaction. ProAssurance entered into a Merger Agreement on March 19, 2025, with The Doctors Company, whereby ProAssurance will become a wholly owned subsidiary. The disclosure confirms that as of June 23, 2026, all required regulatory approvals—including stockholder approval (June 24, 2025), FTC early termination (July 2, 2025), and all insurance regulator approvals—have been received, with closing expected on June 26, 2026. This represents a change of control and material acquisition activity requiring 8-K disclosure under Item 1.01 or 2.01.","company_name":"PROASSURANCE CORP","ticker":"PRA","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10403,"accession_number":"0001127703-26-000024","item_number":"8.01","item_title":"OTHER EVENTS.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the completion of all regulatory approvals for a material merger transaction. ProAssurance entered into a Merger Agreement on March 19, 2025, with The Doctors Company, whereby ProAssurance will become a wholly owned subsidiary. The disclosure confirms that as of June 23, 2026, all required regulatory approvals—including stockholder approval (June 24, 2025), FTC early termination (July 2, 2025), and all insurance regulator approvals—have been received, with closing expected on June 26, 2026. This represents a change of control and material acquisition activity requiring 8-K disclosure under Item 1.01 or 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T21:22:37.545476+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10403,"accession_number":"0001127703-26-000024","item_number":"8.01","item_title":"OTHER EVENTS.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the completion of all regulatory approvals for a material merger transaction. ProAssurance entered into a Merger Agreement on March 19, 2025, with The Doctors Company, whereby ProAssurance will become a wholly owned subsidiary. The disclosure confirms that as of June 23, 2026, all required regulatory approvals—including stockholder approval (June 24, 2025), FTC early termination (July 2, 2025), and all insurance regulator approvals—have been received, with closing expected on June 26, 2026. This represents a change of control and material acquisition activity requiring 8-K disclosure under Item 1.01 or 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T21:22:37.545476+00:00","company_name":"PROASSURANCE CORP","ticker":"PRA","filing_date":"2026-06-23"}]}